Published in Obesity and Diabetes Week, May 16th, 2005
"Peroxisome proliferator-activated receptors (PPARs) are transcription factors involved in both developmental and metabolic functions. There are activated by fatty acids, fatty acid metabolites, and synthetic compounds marketed for their lipid-lowering and antidiabetic actions. It was clearly established that activation of PPAR-alpha and PPAR-gamma, by fibrates and thiazolidinediones, respectively, impair metabolic disorders," a scientist in France reports.
"The implication of the third member of the PPAR family, PPAR-delta, remained evasive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.